wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28261949-4BC1EE48-E94A-42D1-B5F7-2B4084C5D6E7
Q28261949-4BC1EE48-E94A-42D1-B5F7-2B4084C5D6E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28261949-4BC1EE48-E94A-42D1-B5F7-2B4084C5D6E7
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
P2860
Q28261949-4BC1EE48-E94A-42D1-B5F7-2B4084C5D6E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28261949-4BC1EE48-E94A-42D1-B5F7-2B4084C5D6E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
52ed489963e203c88f35c9582ec9b94b9044f0dd
P2860
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.